Simran Preet

939 total citations
35 papers, 733 citations indexed

About

Simran Preet is a scholar working on Microbiology, Molecular Biology and Biomaterials. According to data from OpenAlex, Simran Preet has authored 35 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Microbiology, 16 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in Simran Preet's work include Antimicrobial Peptides and Activities (17 papers), Biochemical and Structural Characterization (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Simran Preet is often cited by papers focused on Antimicrobial Peptides and Activities (17 papers), Biochemical and Structural Characterization (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). Simran Preet collaborates with scholars based in India, Saudi Arabia and Israel. Simran Preet's co-authors include Praveen Rishi, Avneet Saini, Sonia Chauhan, Satish Kumar Pandey, Shubhi Joshi, Sheetal Sharma, Vivek Kumar, Indu Verma, Rajesh Kumar and Amritpal Kaur and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Simran Preet

35 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simran Preet India 16 348 184 143 123 117 35 733
Vijay Singh Gondil India 18 270 0.8× 178 1.0× 87 0.6× 122 1.0× 113 1.0× 35 968
Valentina Puca Italy 15 341 1.0× 126 0.7× 107 0.7× 67 0.5× 66 0.6× 28 782
Agata Dorotkiewicz‐Jach Poland 14 299 0.9× 165 0.9× 75 0.5× 142 1.2× 88 0.8× 20 752
Esteban Nicolás Lorenzón Brazil 18 441 1.3× 423 2.3× 72 0.5× 111 0.9× 56 0.5× 32 829
Maryam Roudbary Iran 20 330 0.9× 219 1.2× 119 0.8× 71 0.6× 97 0.8× 62 1.2k
Madhuri Singh India 10 229 0.7× 140 0.8× 144 1.0× 81 0.7× 56 0.5× 20 785
Majed Halwani Saudi Arabia 17 379 1.1× 203 1.1× 113 0.8× 122 1.0× 63 0.5× 33 961
Setareh Haghighat Iran 17 278 0.8× 46 0.3× 84 0.6× 152 1.2× 142 1.2× 56 861
Ching-Wen Huang Taiwan 6 200 0.6× 88 0.5× 63 0.4× 141 1.1× 141 1.2× 8 745

Countries citing papers authored by Simran Preet

Since Specialization
Citations

This map shows the geographic impact of Simran Preet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Preet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Preet more than expected).

Fields of papers citing papers by Simran Preet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simran Preet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Preet. The network helps show where Simran Preet may publish in the future.

Co-authorship network of co-authors of Simran Preet

This figure shows the co-authorship network connecting the top 25 collaborators of Simran Preet. A scholar is included among the top collaborators of Simran Preet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simran Preet. Simran Preet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshi, Shubhi, et al.. (2025). Advances in biomaterials for wound care management: Insights from recent developments. Advances in Colloid and Interface Science. 343. 103563–103563. 4 indexed citations
2.
Misra, Charu, Mahesh Kumar, Deepak Chitkara, et al.. (2024). Docetaxel-tethered di-Carboxylic Acid Derivatised Fullerenes: A Promising Drug Delivery Approach for Breast Cancer. AAPS PharmSciTech. 25(7). 233–233. 1 indexed citations
3.
Barkat, Md. Abul, Charu Misra, Amena Ali, et al.. (2024). Lipid-based microemulsion gel for the topical delivery of methotrexate: an optimized, rheologically acceptable formulation with conducive dermatokinetics. Archives of Dermatological Research. 316(6). 316–316. 4 indexed citations
4.
Joshi, Shubhi, et al.. (2023). Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics. International Journal of Peptide Research and Therapeutics. 29(4). 61–61. 72 indexed citations
5.
Pandey, Satish Kumar, et al.. (2022). Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer. International Journal of Pharmaceutics. 620. 121744–121744. 42 indexed citations
6.
Sharma, Pratibha, Sheetal Sharma, Shubhi Joshi, et al.. (2022). Design, characterization and structure–function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment. Scientific Reports. 12(1). 12058–12058. 9 indexed citations
8.
Sharma, Sheetal, et al.. (2021). Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics. Colloids and Surfaces B Biointerfaces. 211. 112303–112303. 31 indexed citations
9.
Thotakura, Nagarani, et al.. (2021). Doxorubicin-Loaded Mixed Micelles for the Effective Management of Skin Carcinoma: In Vivo Anti-Tumor Activity and Biodistribution Studies. AAPS PharmSciTech. 22(3). 130–130. 7 indexed citations
10.
Chauhan, Sonia, D. K. Dhawan, Avneet Saini, & Simran Preet. (2021). Antimicrobial peptides against colorectal cancer-a focused review. Pharmacological Research. 167. 105529–105529. 24 indexed citations
12.
Preet, Simran, et al.. (2019). Augmented therapeutic efficacy of 5-fluorouracil in conjunction with lantibiotic nisin against skin cancer. Biochemical and Biophysical Research Communications. 520(3). 551–559. 34 indexed citations
13.
Preet, Simran, et al.. (2018). Augmented antibiotic resistance associated with cadmium induced alterations in Salmonella enterica serovar Typhi. Scientific Reports. 8(1). 15 indexed citations
14.
Kaur, Amritpal, et al.. (2018). Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity. Colloids and Surfaces B Biointerfaces. 176. 62–69. 129 indexed citations
15.
Preet, Simran, et al.. (2017). Management of Staphylococcus Mediated Systemic Infection by Enhancing the Resurging Activity of Co-trimoxazole in Presence of Cryptdin-2. Indian Journal of Microbiology. 57(4). 438–447. 4 indexed citations
16.
Preet, Simran, et al.. (2015). Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy. Tumor Biology. 36(11). 8301–8308. 64 indexed citations
17.
Singh, Aman Preet, Simran Preet, & Praveen Rishi. (2014). Nisin/β-lactam adjunct therapy against Salmonella enterica serovar Typhimurium: a mechanistic approach. Journal of Antimicrobial Chemotherapy. 69(7). 1877–1887. 33 indexed citations
18.
Singh, Aman Preet, Simran Preet, & Praveen Rishi. (2011). Augmentation of antimicrobial activity of conventional antibiotics by cell-free extract of L. plantarum. The Journal of Antibiotics. 64(12). 795–798. 5 indexed citations
19.
Preet, Simran, Sanjay Bharati, Geeta Shukla, Ashwani Koul, & Praveen Rishi. (2011). Evaluation of Amoebicidal Potential of Paneth Cell Cryptdin-2 against Entamoeba histolytica. PLoS neglected tropical diseases. 5(12). e1386–e1386. 17 indexed citations
20.
Rishi, Praveen, Simran Preet, & Prabhjot Kaur. (2011). Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy. Annals of Clinical Microbiology and Antimicrobials. 10(1). 9–9. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026